Table 2 CD133 expression in relation to clinical and pathological parameters in a series of 137 colon cancers
| Â | Total | Low | High | p value |
|---|---|---|---|---|
| Â | Â | n (%) | n (%) | Â |
Gender | ||||
Males | 78 | 41 (53) | 37 (47) | Â |
Females | 59 | 31 (52) | 28 (48) | n.s. |
Age (yr) | ||||
≤68 | 73 | 35 (48) | 38 (52) |  |
>68 | 64 | 37 (58) | 27 (42) | n.s. |
Tumor Grading | ||||
1 | 9 | 4 (44) | 5 (56) | Â |
2 | 86 | 50 (58) | 36 (42) | Â |
3 | 42 | 18 (43) | 24 (57) | n.s. |
pT parameter | ||||
pT1 | 12 | 3 (25) | 9 (75) | Â |
pT2 | 17 | 7 (41) | 10 (59) | Â |
pT3 | 75 | 48 (64) | 27 (36) | Â |
pT4 | 33 | 14 ( 42) | 19 (58) | 0.02 |
Nodal status | ||||
Negative | 76 | 42 (55) | 34 (45) | Â |
Positive | 61 | 30 (49) | 31 (51) | n.s. |
Tumor stage | ||||
I | 25 | 9 (36) | 16 (64) | Â |
II | 43 | 31 (72) | 12 (28) | Â |
III | 69 | 32 (46) | 37 (54) | 0.006 |
Recurrence | ||||
YES | 57 | 22 (39) | 35 (61) | Â |
NOT | 80 | 50 (62) | 30 (37) | 0.005 |
Follow-up | ||||
Deceased | 51 | 20 (39) | 31 (61) | Â |
Alive | 86 | 52 (61) | 34 (39) | 0.013 |
α-DG staining | ||||
Low | 68 | 28 (41) | 40 (59) | Â |
High | 69 | 44 (64) | 25 (36) | 0.006 |